Home » Topics » Briefs » Other news to note

Other news to note
RSS

Xenova: half-year 1997 highlights

Sep. 5, 1997

Xoma: Q2 1997 highlights

Sep. 4, 1997

Texas Biotechnology: Q2 1997 highlights

Sep. 4, 1997

Nippon Roche: products under development

Sep. 4, 1997

CV Therapeutics: Q2 1997 highlights

Sep. 4, 1997

Activated Cell Therapy now named Dendreon Corporation

Sep. 4, 1997

SmithKline Beecham and Incyte form diaDexus

Sep. 4, 1997

Shire acquires Richwood

Sep. 1, 1997

Inex: Q2 1997 highlights

Aug. 29, 1997

Novopharm Biotech, Genesys Pharma receive approval to amalgamate

Aug. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...